Candel Therapeutics (CADL) Other Gross PP&E Adjustments (2020 - 2025)

Candel Therapeutics' Other Gross PP&E Adjustments history runs 6 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• In Q4 2025, Other Gross PP&E Adjustments fell 42.11% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (down 42.11% YoY), while the FY2025 annual figure was $2.2 million, down 42.11% from the prior year.
• Other Gross PP&E Adjustments came in at $2.2 million for Q4 2025 at Candel Therapeutics, up from $1.9 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $4.3 million in Q2 2023 to a low of $1.9 million in Q3 2025.
• A 5-year average of $3.6 million and a median of $3.7 million in 2024 frame the typical range for Other Gross PP&E Adjustments.
• Across the five-year window, Other Gross PP&E Adjustments jumped 47.98% in 2021 and tumbled 53.29% in 2025, its largest moves.
• Candel Therapeutics' Other Gross PP&E Adjustments stood at $3.4 million in 2021, then climbed by 7.9% to $3.6 million in 2022, then retreated by 8.89% to $3.3 million in 2023, then rose by 12.9% to $3.7 million in 2024, then slumped by 42.11% to $2.2 million in 2025.
• According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $2.2 million, $1.9 million, and $3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison